Satoh, T.; Trudler, D.; Oh, C.-K.; Lipton, S.A.
Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer’s Disease, Parkinson’s Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome. Antioxidants 2022, 11, 124.
https://doi.org/10.3390/antiox11010124
AMA Style
Satoh T, Trudler D, Oh C-K, Lipton SA.
Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer’s Disease, Parkinson’s Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome. Antioxidants. 2022; 11(1):124.
https://doi.org/10.3390/antiox11010124
Chicago/Turabian Style
Satoh, Takumi, Dorit Trudler, Chang-Ki Oh, and Stuart A. Lipton.
2022. "Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer’s Disease, Parkinson’s Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome" Antioxidants 11, no. 1: 124.
https://doi.org/10.3390/antiox11010124
APA Style
Satoh, T., Trudler, D., Oh, C.-K., & Lipton, S. A.
(2022). Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer’s Disease, Parkinson’s Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome. Antioxidants, 11(1), 124.
https://doi.org/10.3390/antiox11010124